UK, US drug pricing deal to cost £1bn over three years
A new UK-US pharmaceutical agreement will result in the National Health Service incurring costs of £1 billion over the next three years due to increased medicine prices and tariff exemptions.
A compact global news feed for the bigger picture.
A new UK-US pharmaceutical agreement will result in the National Health Service incurring costs of £1 billion over the next three years due to increased medicine prices and tariff exemptions.
Loading Intelligence...
Select a report from the feed to view analysis and related coverage.
A compact global news feed for the bigger picture. It pulls reporting from outlets around the world so you can compare what gets covered, what gets missed, and how it’s framed.
It can feel dense at first (on purpose): more signal, less fluff. No ads. No trackers. No agenda.